Comfort starts before the procedure.
A prescription topical anaesthetic cream designed to provide local dermal analgesia prior to certain superficial dermatological procedures.
Pliaglis® is a prescription topical anaesthetic cream combining lidocaine and tetracaine at 7%/7%, creating a eutectic formulation that delivers strong local dermal anesthesia directly through the skin.
Technology designed to simplify topical anaesthesia.
Pliaglis® proprietary peel technology provides uniform anesthesia across the targeted area and easily peels off. A distinctive approach to preparing the skin before superficial procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing and laser-assisted tattoo removal.
A topical anaesthetic formulation combining two high-concentration active ingredients with proprietary peel-off cream technology to support preparation for certain superficial dermatological procedures.
Request a Demo-
Lidocaine 7%
-
Tetracaine 7%
-
Proprietary Peel technology
Explore the clinical evidence behind Pliaglis®
Access a Clinical Study to explore the efficacy, safety and use of Pliaglis® prior to certain superficial dermatological procedures in greater depth.
Would you like more information about our medical brands?
Request a demoFrequently Asked Questions about Pliaglis®
Find answers to common questions about Pliaglis®, its anaesthetic formulation, Peel technology and professional use.
-
Pliaglis® is a prescription topical anaesthetic cream containing 7% lidocaine and 7% tetracaine. It provides local dermal analgesia on intact skin prior to certain superficial dermatological procedures.
-
The formulation uses proprietary phase-changing topical technology. Following application, the cream forms a layer that can be peeled away before the procedure, distinguishing Pliaglis® from conventional topical anaesthetic creams.
-
Pliaglis® is indicated prior to certain superficial dermatological procedures. Crescita lists applications including dermal filler injections, certain laser treatments and laser-assisted tattoo removal. Use should follow the approved indications.
-
Pliaglis® contains two local anaesthetics: lidocaine at 7% and tetracaine at 7%. They are incorporated into the product’s proprietary phase-changing formulation.
-
Yes. Pliaglis® is a prescription topical anaesthetic. Its use should follow the product monograph, approved indications and the direction of a healthcare professional.
